You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ferriprox

Showing 1 - 25 of 33
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pantothenate Kinase-Associated Neurodegeneration Trial (Deferiprone)

No longer available
  • Pantothenate Kinase-Associated Neurodegeneration
  • (no location specified)
Nov 9, 2022

Iron Overload, Sickle Cell Disease, Other Anemias Trial in Worldwide (Deferiprone, Deferoxamine)

Terminated
Has Results
  • Iron Overload
  • +2 more
  • Oakland, California
  • +32 more
Jul 16, 2021

Beta Thalassemia Major Anemia, Iron Overload Trial in Cairo, Jakarta (Deferiprone oral solution, Placebo)

Completed
  • Beta Thalassemia Major Anemia
  • Iron Overload
  • Deferiprone oral solution
  • Placebo
  • Cairo, Egypt
  • +3 more
Feb 9, 2021

Parkinson's Disease Trial in London (Deferiprone 20mg, Placebo, Deferiprone 30mg)

Completed
Has Results
  • Parkinson's Disease
  • Deferiprone 20mg
  • +2 more
  • London, United Kingdom
    Centre for Neuroscience, Imperial College London
Jun 3, 2020

Deferiprone (Ferriprox®) in Treatment of Superficial Siderosis

Completed
Has Results
  • Superficial Siderosis
    • Baltimore, Maryland
      Johns Hopkins University
    Aug 26, 2019

    Parkinson's Disease, Amyotrophic Lateral Sclerosis, Oxidative Stress Trial in Lille (deferiprone, )

    Completed
    • Parkinson's Disease
    • +3 more
    • Lille, France
      Hôpital Roger Salengro, CHRU de Lille
    Mar 25, 2020

    Iron Overload Due to Repeated Red Blood Cell Transfusions Trial in Worldwide (Deferiprone DR tablets 1000 mg (Low dosage),

    Completed
    Has Results
    • Iron Overload Due to Repeated Red Blood Cell Transfusions
    • Deferiprone DR tablets 1000 mg (Low dosage)
    • Deferiprone DR tablets 1000 mg (High dosage)
    • Chicago, Illinois
    • +4 more
    Jun 17, 2021

    Iron Overload, Sickle Cell Disease, Other Anemias Trial in Worldwide (Deferiprone)

    Unknown status
    • Iron Overload
    • +2 more
    • Oakland, California
    • +12 more
    Jan 10, 2019

    Thalassemia Major With Severe Transfusional Iron Overload Trial in Chicago, Philadelphia (Deferasirox and deferiprone)

    Completed
    Has Results
    • Thalassemia Major With Severe Transfusional Iron Overload
    • Deferasirox and deferiprone
    • Chicago, Illinois
    • +1 more
    Feb 13, 2019

    Myelodysplastic Syndrome With Low-grade Lesions, Iron Overload Due to Repeated Red Blood Cell Transfusions Trial in Tel Hashomer

    Completed
    • Myelodysplastic Syndrome With Low-grade Lesions
    • Iron Overload Due to Repeated Red Blood Cell Transfusions
    • Tel Hashomer, Israel
      Chim Sheba Medical Center
    Oct 30, 2018

    Mild Cognitive Impairment Trial in San Antonio (Deferiprone, Placebo phase)

    Withdrawn
    • Mild Cognitive Impairment
    • San Antonio, Texas
      University of Texas Health Science Center
    Feb 5, 2018

    Pantothenate Kinase-Associated Neurodegeneration Trial in Worldwide (Deferiprone oral solution)

    Completed
    Has Results
    • Pantothenate Kinase-Associated Neurodegeneration
    • Deferiprone oral solution
    • Oakland, California
    • +3 more
    Aug 12, 2020

    ALS (Amyotrophic Lateral Sclerosis), Iron Overload Trial in Lille (Deferiprone)

    Completed
    • ALS (Amyotrophic Lateral Sclerosis)
    • Iron Overload
    • Lille, France
      Hôpital Roger Salengro, CHRU de Lille
    Mar 8, 2017

    Pantothenate Kinase-Associated Neurodegeneration Trial in Worldwide (Deferiprone oral solution, Placebo)

    Completed
    Has Results
    • Pantothenate Kinase-Associated Neurodegeneration
    • Deferiprone oral solution
    • Placebo
    • Oakland, California
    • +3 more
    Jun 27, 2019

    Bioequivalence Trial in Erfurt (Deferiprone 500Mg Tablet, Deferiprone 500 MG Oral Tablet [Ferriprox])

    Completed
    • Bioequivalence
    • Deferiprone 500Mg Tablet
    • Deferiprone 500 MG Oral Tablet [Ferriprox]
    • Erfurt, Thüringen, Germany
      SocraTec R&D GmbH Clinical Pharmacology Unit
    Dec 6, 2016

    Diabetes, Iron Metabolism Disorders, Gastroduodenal Ulcer Trial in Jerusalem (Deferiprone, Acetylcysteine, Sitagliptin and

    Unknown status
    • Diabetes Mellitus
    • +5 more
    • Jerusalem, Israel
      Hadassah medical center
    Aug 24, 2016

    Healthy Trial in Mount-Royal (Deferiprone extended release, Deferiprone immediate release)

    Completed
    Has Results
    • Healthy
    • Deferiprone extended release
    • Deferiprone immediate release
    • Mount-Royal, Quebec, Canada
      Algorithme Pharma Inc.
    Jan 27, 2016

    Healthy Trial in Toronto (Deferiprone sustained-release, Deferiprone immediate-release)

    Completed
    Has Results
    • Healthy
    • Deferiprone sustained-release
    • Deferiprone immediate-release
    • Toronto, Ontario, Canada
      Apotex Inc. BioClinical Development
    Apr 14, 2016

    Healthy Trial in Mount-Royal (Deferiprone delayed release tablet formulation, Deferiprone oral solution)

    Completed
    Has Results
    • Healthy
    • Deferiprone delayed release tablet formulation
    • Deferiprone oral solution
    • Mount-Royal, Quebec, Canada
      Algorithme Pharma Inc.
    Apr 8, 2016

    Sickle Cell Disease Trial in Montreal (single 1500 mg dose of Ferriprox)

    Completed
    Has Results
    • Sickle Cell Disease
    • single 1500 mg dose of Ferriprox
    • Montreal, Quebec, Canada
      CHUM-Hôpital Notre-Dame
    Jul 22, 2015

    Beta Thalassemia Major Trial in Cairo (Deferiprone)

    Unknown status
    • Beta Thalassemia Major
    • Cairo, Egypt
      Pediatric Hematology clinic, Ain Shams University
    Jan 13, 2015

    Beta-thalassemia, Serum Ferritin, Iron Chelation Therapy Trial in Cairo (desferal, ferriprox, blood transfusion)

    Unknown status
    • Beta-thalassemia
    • +2 more
    • desferal, ferriprox, blood transfusion
    • Cairo, Egypt
      Pediatric Hematology clinic, Ain Shams University
    Jan 13, 2015

    Healthy Volunteers Trial in Mont-Royal (Deferiprone, Placebo)

    Completed
    Has Results
    • Healthy Volunteers
    • Mont-Royal, Quebec, Canada
      Algorithme Pharma Inc.
    Dec 4, 2014

    Hepatic Impairment Trial in Miami, Orlando (Ferriprox®)

    Completed
    Has Results
    • Hepatic Impairment
    • Miami, Florida
    • +1 more
    Sep 3, 2014

    Prolonged QTc Interval Trial in Tempe (Deferiprone, deferiprone matching tablets, moxifloxacin)

    Completed
    Has Results
    • Prolonged QTc Interval
    • Tempe, Arizona
      Celerion
    Nov 7, 2014